Rewriting human health,

one cell at a time

Products | ioCells

Deterministically programmed human iPSC-derived cells for research and drug discovery

Discover ioCells
iocells_vial_radial_0

Cell coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency. 

Explore our platform
bitbio-platform_diagram-horizontal-no_BG-V2.1 bitbio-platform_diagram-vertical-no_BG-min

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

Learn more

Latest news

bit.bio launches first-of-their-kind human iPSC-derived cells for gene activation and interference, expanding functional genomics product range Press Release
bit.bio launches first-of-their-kind human iPSC-derived cells for gene activation and interference, expanding functional genomics product range 03.03.2025
Published by bit.bio
Read now
bit.bio Launches ioTracker Cells Range at SLAS 2025 Press Release
bit.bio Launches ioTracker Cells Range at SLAS 2025 03.02.2025
Published by bit.bio
Read now
bit.bio Raises $30 Million Led by M&G Investments Press Release
bit.bio Raises $30 Million Led by M&G Investments 16.12.2024
Published by bit.bio
Read now
Insights from iGEM Judge Andreas: Exploring Synthetic Biology, Innovation, and Future Bioengineers News
Insights from iGEM Judge Andreas: Exploring Synthetic Biology, Innovation, and Future Bioengineers 17.10.2024
Published by bit.bio
Read now